Overall, these observations indicate that the reduction in tumor growth following NLRP3 inhibition is not mediated by a reduction in tumor cell proliferation or by a direct effect on CD8+ T cells, but rather by the reduction MDSCs expansion and their immunosuppressive activities. Here, NLRP3 is linked to neoplasm.